Post the six-month follow-up, myocardial infarction was reported in four (3.85%) patients in total, out of which one (1.39%) was in the low hs-CRP group and three (9.38%) were in the high hs-CRP group, though this is not statistically significant (P=>0.085). Here, MAP3K14 is linked to myocardial infarction.